Allscripts Healthcare Solutions (MDRX) Stock Rating Lowered by BidaskClub

Allscripts Healthcare Solutions (NASDAQ:MDRX) was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating in a report issued on Friday.

Other equities research analysts have also recently issued reports about the stock. Evercore ISI initiated coverage on shares of Allscripts Healthcare Solutions in a research report on Thursday. They issued a $17.50 price target for the company. Dougherty & Co reissued a “buy” rating and issued a $16.00 price target (up from $15.00) on shares of Allscripts Healthcare Solutions in a research report on Tuesday, October 3rd. Cantor Fitzgerald reissued a “buy” rating and issued a $17.00 price target on shares of Allscripts Healthcare Solutions in a research report on Wednesday, September 27th. Robert W. Baird reissued a “buy” rating and issued a $16.00 price target on shares of Allscripts Healthcare Solutions in a research report on Tuesday, October 17th. Finally, Zacks Investment Research raised shares of Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating and set a $14.00 price target for the company in a research report on Tuesday, November 7th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and ten have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $15.66.

Allscripts Healthcare Solutions (NASDAQ:MDRX) opened at $15.09 on Friday. The company has a debt-to-equity ratio of 1.20, a quick ratio of 0.98 and a current ratio of 0.98. The company has a market cap of $2,730.00, a price-to-earnings ratio of -13.01, a P/E/G ratio of 2.16 and a beta of 1.32. Allscripts Healthcare Solutions has a 12 month low of $11.01 and a 12 month high of $16.13.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last announced its quarterly earnings results on Thursday, November 2nd. The software maker reported $0.12 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.12. Allscripts Healthcare Solutions had a negative net margin of 12.23% and a positive return on equity of 6.53%. analysts expect that Allscripts Healthcare Solutions will post 0.46 EPS for the current year.

In other news, EVP Brian Farley sold 5,000 shares of the company’s stock in a transaction dated Thursday, December 14th. The shares were sold at an average price of $14.35, for a total value of $71,750.00. Following the completion of the sale, the executive vice president now directly owns 191,607 shares of the company’s stock, valued at $2,749,560.45. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP James Hewitt sold 36,796 shares of the company’s stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $14.11, for a total transaction of $519,191.56. Following the completion of the sale, the senior vice president now directly owns 181,766 shares of the company’s stock, valued at $2,564,718.26. The disclosure for this sale can be found here. Insiders sold 56,796 shares of company stock valued at $804,842 over the last ninety days. Corporate insiders own 0.75% of the company’s stock.

Several large investors have recently made changes to their positions in the company. Oakbrook Investments LLC purchased a new stake in shares of Allscripts Healthcare Solutions in the fourth quarter valued at about $194,000. Dalton Greiner Hartman Maher & Co. increased its stake in shares of Allscripts Healthcare Solutions by 18.4% during the fourth quarter. Dalton Greiner Hartman Maher & Co. now owns 2,990,902 shares of the software maker’s stock worth $43,518,000 after acquiring an additional 465,037 shares during the period. GSA Capital Partners LLP acquired a new position in shares of Allscripts Healthcare Solutions during the third quarter worth about $340,000. Neuberger Berman Group LLC increased its stake in shares of Allscripts Healthcare Solutions by 5.5% during the third quarter. Neuberger Berman Group LLC now owns 3,676,088 shares of the software maker’s stock worth $52,311,000 after acquiring an additional 190,158 shares during the period. Finally, California Public Employees Retirement System increased its stake in shares of Allscripts Healthcare Solutions by 5.6% during the third quarter. California Public Employees Retirement System now owns 506,028 shares of the software maker’s stock worth $7,201,000 after acquiring an additional 26,928 shares during the period.

ILLEGAL ACTIVITY WARNING: This news story was originally posted by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this news story on another website, it was stolen and republished in violation of US and international copyright and trademark legislation. The legal version of this news story can be accessed at https://sportsperspectives.com/2018/01/19/allscripts-healthcare-solutions-mdrx-stock-rating-lowered-by-bidaskclub.html.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Analyst Recommendations for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply